2,N,N-TMT

Last updated

2,N,N-TMT
2-Me-DMT.svg
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
  • (2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C13H18N2
Molar mass 202.301 g·mol−1
3D model (JSmol)
  • Cc1c(c2ccccc2[nH]1)CCN(C)C
  • InChI=1S/C13H18N2/c1-10-11(8-9-15(2)3)12-6-4-5-7-13(12)14-10/h4-7,14H,8-9H2,1-3H3
  • Key:NDGCOWDSLVNLGE-UHFFFAOYSA-N
   (verify)

2,N,N-Trimethyltryptamine (2,N,N-TMT), also known as 2-methyl-N,N-dimethyltryptamine (2-Me-DMT), is a tryptamine derivative. [1] It is not a psychedelic, but instead produces tactile enhancement and auditory distortion. [1] The drug was invented by Alexander Shulgin and reported in his book TiHKAL (#34). [1]

Contents

Effects

2-Me-DMT is claimed to show psychoactive effects at a dosage of 50–100 mg orally, but these are relatively mild compared to other similar drugs. [1] This suggests that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5-HT2A receptor target that mediates the hallucinogenic effects of these drugs.

The specific effects produced by 2-Me-DMT included tingling, mild stomach rumbling, mild relaxation, skin "alerting" especially on the head and neck, bodily/tactile activation and heightened sensitivity, auditory distortion, and altered tonal perception. [1] There were no visuals, no cloudiness of thought processes, no motor impairment, but sexual activity was said to be enhanced. [1] There were no changes in appetite, no gastrointestinal problems, and no after-effects the next day. [1] The drug was described as not being a psychedelic or psychostimulant, but instead being a specific "tactile stimulant" and sexual enhancer. [1]

Pharmacology

Its affinities (Ki) for the serotonin 5-HT1A and 5-HT2A receptor were 4,598 nM and 15,037 nM, respectively. [2] [3] These affinities were dramatically lower than those of dimethyltryptamine (DMT) in the same study, which were 87 nM and 1,513 nM, respectively. [2] [3] Hence, 2-Me-DMT appears to show approximately 53- and 10-fold lower affinities for the serotonin 5-HT1A and 5-HT2A receptors compared to DMT. [2] [3] In addition, unlike DMT, 2-Me-DMT failed to activate the serotonin 5-HT1A and 5-HT2A receptors. [3] Despite the preceding findings however, 2-Me-DMT induces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents, and does so to a similar magnitude as 5-MeO-DMT. [3]

In studies of other 2-methyltryptamines, specifically 2-methyl-5-MeO-DALT and 2-methyl-5-F-DALT, these compounds had variably reduced affinities for serotonin receptors and, in contrast to 2-Me-DMT, did not produce the head-twitch response. [4]

Sweden's public health agency suggested classifying 2-Me-DMT as a hazardous substance, on May 15, 2019. [5]

See also

References

  1. 1 2 3 4 5 6 7 8 "#34 2-ME-DMT". Erowid Online Books : "TIHKAL".
  2. 1 2 3 Chen X, Li J, Yu L, Maule F, Chang L, Gallant JA, et al. (October 2023). "A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines". J Biol Chem. 299 (10): 105231. doi: 10.1016/j.jbc.2023.105231 . PMC   10570959 . PMID   37690691.
  3. 1 2 3 4 5 Chen X, Li J, Yu L, Dhananjaya D, Maule F, Cook S, et al. (10 March 2023), Bioproduction platform using a novel cane toad (Rhinella marina) N-methyltransferase for psychedelic-inspired drug discovery (PDF), doi: 10.21203/rs.3.rs-2667175/v1 , retrieved 17 March 2025
  4. ↑ Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL (November 2018). "Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs". Neuropharmacology. 142: 231–239. doi:10.1016/j.neuropharm.2018.02.028. PMC   6230509 . PMID   29499272.
  5. ↑ "Folkhälsomyndigheten föreslår att 20 ämnen klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 15 May 2019. Archived from the original on 20 October 2021. Retrieved 11 November 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.